D-aspartate + interferon beta-1a + methylprednisolone

This is a combination of three agents:

• D-aspartate is an endogenous amino acid, sometimes used as a dietary supplement, with roles in neurotransmission and hormone regulation. It is not an approved pharmaceutical drug.
• Interferon beta-1a is a recombinant human protein belonging to the interferon class, used as an immunomodulator primarily for the treatment of relapsing forms of multiple sclerosis. It works by binding to specific cell surface receptors and modulating immune responses, reducing inflammation and preventing nerve damage.
• Methylprednisolone is a synthetic glucocorticoid corticosteroid that acts as an anti-inflammatory and immunosuppressant. It modifies the body's immune response and reduces inflammation in various conditions including autoimmune diseases like multiple sclerosis.

There are no known approved pharmaceutical products or brand names for this exact combination; it appears to be either experimental or theoretical.